{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:52:26Z","timestamp":1789635146718,"version":"4.0.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1038\/ncpgasthep0881","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T10:07:44Z","timestamp":1185962864000},"page":"454-462","source":"Crossref","is-referenced-by-count":84,"title":["Mechanisms of Disease: chronic inflammation and cancer in the pancreas\u2014a potential role for pancreatic stellate cells?"],"prefix":"10.1038","volume":"4","author":[{"given":"Hana","family":"Alg\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Treiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lesina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpgasthep0881_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/jjco\/hyh045","volume":"34","author":"AB Lowenfels","year":"2004","unstructured":"Lowenfels AB and Maisonneuve P (2004) Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34: 238\u2013244","journal-title":"Jpn J Clin Oncol"},{"key":"BFncpgasthep0881_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A  et al. (2005) Cancer statistics 2005. CA Cancer J Clin 55: 10\u201330","journal-title":"CA Cancer J Clin"},{"key":"BFncpgasthep0881_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.0.CO;2-8","volume":"67","author":"DC Allison","year":"1998","unstructured":"Allison DC  et al. (1998) DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol 67: 151\u2013159","journal-title":"J Surg Oncol"},{"key":"BFncpgasthep0881_CR4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0002-9440(10)65054-7","volume":"156","author":"RH Hruban","year":"2000","unstructured":"Hruban RH  et al. (2000) Genetic progression in the pancreatic ducts. Am J Pathol 156: 1821\u20131825","journal-title":"Am J Pathol"},{"key":"BFncpgasthep0881_CR5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris HA 3rd  et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403\u20132413","journal-title":"J Clin Oncol"},{"key":"BFncpgasthep0881_CR6","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ  et al. (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25: 1960\u20131966","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"BFncpgasthep0881_CR7","first-page":"12","volume":"3","author":"D Cunningham","year":"2005","unstructured":"Cunningham D  et al. (2005) Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer [abstract]. Eur J Cancer 3 (Suppl): 12","journal-title":"Eur J Cancer"},{"key":"BFncpgasthep0881_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1067\/mcn.2002.129579","volume":"26","author":"TP Yeo","year":"2002","unstructured":"Yeo TP  et al. (2002) Pancreatic cancer. Curr Probl Cancer 26: 176\u2013275","journal-title":"Curr Probl Cancer"},{"key":"BFncpgasthep0881_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1158\/0008-5472.CAN-05-3914","volume":"66","author":"RH Hruban","year":"2006","unstructured":"Hruban RH  et al. (2006) Pancreatic cancer in mice and man: the Penn Workshop 2004. Cancer Res 66: 14\u201317","journal-title":"Cancer Res"},{"key":"BFncpgasthep0881_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","volume":"53","author":"C Almoguera","year":"1988","unstructured":"Almoguera C  et al. (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549\u2013554","journal-title":"Cell"},{"key":"BFncpgasthep0881_CR11","first-page":"545","volume":"143","author":"RH Hruban","year":"1993","unstructured":"Hruban RH  et al. (1993) K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143: 545\u2013554","journal-title":"Am J Pathol"},{"key":"BFncpgasthep0881_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR  et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437\u2013450","journal-title":"Cancer Cell"},{"key":"BFncpgasthep0881_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/0008-5472.CAN-05-2168","volume":"66","author":"RH Hruban","year":"2006","unstructured":"Hruban RH  et al. (2006) Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66: 95\u2013106","journal-title":"Cancer Res"},{"key":"BFncpgasthep0881_CR14","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1056\/NEJM199305203282001","volume":"328","author":"AB Lowenfels","year":"1993","unstructured":"Lowenfels AB  et al. (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328: 1433\u20131437","journal-title":"N Engl J Med"},{"key":"BFncpgasthep0881_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/gut.51.6.849","volume":"51","author":"D Malka","year":"2002","unstructured":"Malka D  et al. (2002) Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51: 849\u2013852","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0889-8553(02)00004-3","volume":"31","author":"DC Whitcomb","year":"2002","unstructured":"Whitcomb DC and Pogue-Geile K (2002) Pancreatitis as a risk for pancreatic cancer. Gastroenterol Clin North Am 31: 663\u2013678","journal-title":"Gastroenterol Clin North Am"},{"key":"BFncpgasthep0881_CR17","volume-title":"Die krankhaften Geschw\u00fclste","author":"R Virchow","year":"1863","unstructured":"Virchow R (1863\u20131865) Die krankhaften Geschw\u00fclste, edn 1 (3 vols). Berlin: August Hirschwald"},{"key":"BFncpgasthep0881_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M and Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749\u2013759","journal-title":"Nat Rev Immunol"},{"key":"BFncpgasthep0881_CR19","doi-asserted-by":"publisher","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","volume":"287","author":"SH Itzkowitz","year":"2004","unstructured":"Itzkowitz SH and Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7\u2013G17","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0881_CR20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/00042737-199612000-00009","volume":"8","author":"GA Moody","year":"1996","unstructured":"Moody GA  et al. (1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8: 1179\u20131183","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFncpgasthep0881_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM and Werb Z (2002) Inflammation and cancer. Nature 420: 860\u2013867","journal-title":"Nature"},{"key":"BFncpgasthep0881_CR22","doi-asserted-by":"publisher","first-page":"G515","DOI":"10.1152\/ajpgi.00475.2003","volume":"286","author":"M Macarthur","year":"2004","unstructured":"Macarthur M  et al. (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286: G515\u2013G520","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0881_CR23","doi-asserted-by":"publisher","first-page":"G315","DOI":"10.1152\/ajpgi.00115.2004","volume":"287","author":"DC Whitcomb","year":"2004","unstructured":"Whitcomb DC (2004) Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287: G315\u2013G319","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0881_CR24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jnci\/89.6.442","volume":"89","author":"AB Lowenfels","year":"1997","unstructured":"Lowenfels AB  et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89: 442\u2013446","journal-title":"J Natl Cancer Inst"},{"key":"BFncpgasthep0881_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S1542-3565(04)00013-8","volume":"2","author":"N Howes","year":"2004","unstructured":"Howes N  et al. (2004) Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2: 252\u2013261","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFncpgasthep0881_CR26","first-page":"2649","volume":"63","author":"CD Logsdon","year":"2003","unstructured":"Logsdon CD  et al. (2003) Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649\u20132657","journal-title":"Cancer Res"},{"key":"BFncpgasthep0881_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng1096-141","volume":"14","author":"DC Whitcomb","year":"1996","unstructured":"Whitcomb DC  et al. (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14: 141\u2013145","journal-title":"Nat Genet"},{"key":"BFncpgasthep0881_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/76088","volume":"25","author":"H Witt","year":"2000","unstructured":"Witt H  et al. (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25: 213\u2013216","journal-title":"Nat Genet"},{"issue":"Suppl 2","key":"BFncpgasthep0881_CR29","first-page":"ii31","volume":"52","author":"H Witt","year":"2003","unstructured":"Witt H (2003) Chronic pancreatitis and cystic fibrosis. Gut 52 (Suppl 2): ii31\u2013ii41","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/gast.2001.22586","volume":"120","author":"B Etemad","year":"2001","unstructured":"Etemad B and Whitcomb DC (2001) Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120: 682\u2013707","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0881_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00428-003-0958-0","volume":"445","author":"Kloppel","year":"2004","unstructured":"Kloppel  et al. (2004) Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch 445: 1\u20138","journal-title":"Virchows Arch"},{"key":"BFncpgasthep0881_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/gut.43.1.128","volume":"43","author":"MV Apte","year":"1998","unstructured":"Apte MV  et al. (1998) Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43: 128\u2013133","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0016-5085(98)70209-4","volume":"115","author":"MG Bachem","year":"1998","unstructured":"Bachem MG  et al. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115: 421\u2013432","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0881_CR34","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0002-9440(10)65490-9","volume":"155","author":"A Schmid-Kotsas","year":"1999","unstructured":"Schmid-Kotsas A  et al. (1999) Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells. Am J Pathol 155: 1749\u20131758","journal-title":"Am J Pathol"},{"key":"BFncpgasthep0881_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/labinvest.3780007","volume":"80","author":"T Luttenberger","year":"2000","unstructured":"Luttenberger T  et al. (2000) Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest 80: 47\u201355","journal-title":"Lab Invest"},{"key":"BFncpgasthep0881_CR36","doi-asserted-by":"publisher","first-page":"C532","DOI":"10.1152\/ajpcell.2001.281.2.C532","volume":"281","author":"E Schneider","year":"2001","unstructured":"Schneider E  et al. (2001) Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol 281: C532\u2013C543","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFncpgasthep0881_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/gut.50.4.535","volume":"50","author":"P Mews","year":"2002","unstructured":"Mews P  et al. (2002) Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 50: 535\u2013541","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR38","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gut.44.4.534","volume":"44","author":"MV Apte","year":"1999","unstructured":"Apte MV  et al. (1999) Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44: 534\u2013541","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1006\/jsre.2002.6403","volume":"104","author":"T Yokota","year":"2002","unstructured":"Yokota T  et al. (2002) Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis. J Surg Res 104: 106\u2013111","journal-title":"J Surg Res"},{"key":"BFncpgasthep0881_CR40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00006676-200311000-00008","volume":"27","author":"MV Apte","year":"2003","unstructured":"Apte MV and Wilson JS (2003) Stellate cell activation in alcoholic pancreatitis. Pancreas 27: 316\u2013320","journal-title":"Pancreas"},{"key":"BFncpgasthep0881_CR41","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/gut.52.5.677","volume":"52","author":"PA Phillips","year":"2003","unstructured":"Phillips PA  et al. (2003) Cell migration: a novel aspect of pancreatic stellate cell biology. Gut 52: 677\u2013682","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR42","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.bcp.2003.11.013","volume":"67","author":"JA McCarroll","year":"2004","unstructured":"McCarroll JA  et al. (2004) Pancreatic stellate cell migration: role of the phosphatidylinositol 3-kinase (PI3-kinase) pathway. Biochem Pharmacol 67: 1215\u20131225","journal-title":"Biochem Pharmacol"},{"key":"BFncpgasthep0881_CR43","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3748\/wjg.v11.i39.6144","volume":"11","author":"A Masamune","year":"2005","unstructured":"Masamune A  et al. (2005) Endothelin-1 stimulates contraction and migration of rat pancreatic stellate cells. World J Gastroenterol 11: 6144\u20136151","journal-title":"World J Gastroenterol"},{"key":"BFncpgasthep0881_CR44","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S0002-9440(10)61125-X","volume":"160","author":"FW Shek","year":"2002","unstructured":"Shek FW  et al. (2002) Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 160: 1787\u20131798","journal-title":"Am J Pathol"},{"key":"BFncpgasthep0881_CR45","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1053\/j.gastro.2005.06.067","volume":"129","author":"R Gao","year":"2005","unstructured":"Gao R and Brigstock DR (2005) Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor. Gastroenterology 129: 1019\u20131030","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0881_CR46","doi-asserted-by":"publisher","first-page":"G164","DOI":"10.1152\/ajpgi.2001.280.1.G164","volume":"280","author":"R Vogelmann","year":"2001","unstructured":"Vogelmann R  et al. (2001) Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 280: G164\u2013G172","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0881_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/gut.51.4.579","volume":"51","author":"R Jaster","year":"2002","unstructured":"Jaster R  et al. (2002) Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 51: 579\u2013584","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR48","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/gut.52.10.1487","volume":"52","author":"N Ohnishi","year":"2003","unstructured":"Ohnishi N  et al. (2003) Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 52: 1487\u20131493","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00006676-200307000-00010","volume":"27","author":"H Klonowski-Stumpe","year":"2003","unstructured":"Klonowski-Stumpe H  et al. (2003) Production and effects of endothelin-1 in rat pancreatic stellate cells. Pancreas 27: 67\u201374","journal-title":"Pancreas"},{"key":"BFncpgasthep0881_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/00006676-200207000-00018","volume":"25","author":"A Masamune","year":"2002","unstructured":"Masamune A  et al. (2002) Activated rat pancreatic stellate cells express intercellular adhesion molecule-1 (ICAM-1) in vitro. Pancreas 25: 78\u201385","journal-title":"Pancreas"},{"key":"BFncpgasthep0881_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00006676-200410000-00002","volume":"29","author":"MV Apte","year":"2004","unstructured":"Apte MV  et al. (2004) Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 29: 179\u2013187","journal-title":"Pancreas"},{"key":"BFncpgasthep0881_CR52","first-page":"2690","volume":"36","author":"AL Cubilla","year":"1976","unstructured":"Cubilla AL and Fitzgerald PJ (1976) Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 36: 2690\u20132698","journal-title":"Cancer Res"},{"key":"BFncpgasthep0881_CR53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1053\/j.gastro.2004.12.036","volume":"128","author":"MG Bachem","year":"2005","unstructured":"Bachem MG  et al. (2005) Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128: 907\u2013921","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0881_CR54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00006676-200611000-00123","volume":"33","author":"SV Joshi","year":"2006","unstructured":"Joshi SV  et al. (2006) Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer. Pancreas 33: 472\u2013473","journal-title":"Pancreas"},{"key":"BFncpgasthep0881_CR55","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00268-004-7147-4","volume":"28","author":"M Hartel","year":"2004","unstructured":"Hartel M  et al. (2004) Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg 28: 818\u2013825","journal-title":"World J Surg"},{"key":"BFncpgasthep0881_CR56","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1158\/0008-5472.CAN-06-0081","volume":"66","author":"N Dornhofer","year":"2006","unstructured":"Dornhofer N  et al. (2006) Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 66: 5816\u20135827","journal-title":"Cancer Res"},{"key":"BFncpgasthep0881_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1158\/1535-7163.MCT-05-0516","volume":"5","author":"T Aikawa","year":"2006","unstructured":"Aikawa T  et al. (2006) Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther 5: 1108\u20131116","journal-title":"Mol Cancer Ther"},{"key":"BFncpgasthep0881_CR58","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1101\/gad.1415606","volume":"20","author":"AF Hezel","year":"2006","unstructured":"Hezel AF  et al. (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20: 1218\u20131249","journal-title":"Genes Dev"},{"key":"BFncpgasthep0881_CR59","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0016-5085(98)70098-8","volume":"115","author":"M Wagner","year":"1998","unstructured":"Wagner M  et al. (1998) Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology 115: 1254\u20131262","journal-title":"Gastroenterology"},{"key":"BFncpgasthep0881_CR60","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1158\/1078-0432.CCR-03-0825","volume":"10","author":"T Armstrong","year":"2004","unstructured":"Armstrong T  et al. (2004) Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10: 7427\u20137437","journal-title":"Clin Cancer Res"},{"key":"BFncpgasthep0881_CR61","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/path.1935","volume":"208","author":"I Esposito","year":"2006","unstructured":"Esposito I  et al. (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208: 673\u2013685","journal-title":"J Pathol"},{"key":"BFncpgasthep0881_CR62","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1158\/1078-0432.CCR-1190-03","volume":"10","author":"J Koninger","year":"2004","unstructured":"Koninger J  et al. (2004) Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action. Clin Cancer Res 10: 4776\u20134783","journal-title":"Clin Cancer Res"},{"key":"BFncpgasthep0881_CR63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.bbrc.2004.08.008","volume":"322","author":"J Koninger","year":"2004","unstructured":"Koninger J  et al. (2004) Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Commun 322: 943\u2013949","journal-title":"Biochem Biophys Res Commun"},{"key":"BFncpgasthep0881_CR64","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/gut.52.2.275","volume":"52","author":"PA Phillips","year":"2003","unstructured":"Phillips PA  et al. (2003) Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut 52: 275\u2013282","journal-title":"Gut"},{"key":"BFncpgasthep0881_CR65","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1172\/JCI0215051","volume":"109","author":"HC Crawford","year":"2002","unstructured":"Crawford HC  et al. (2002) Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 109: 1437\u20131444","journal-title":"J Clin Invest"},{"key":"BFncpgasthep0881_CR66","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.ejca.2005.04.044","volume":"41","author":"G Garcea","year":"2005","unstructured":"Garcea G  et al. (2005) Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41: 2213\u20132236","journal-title":"Eur J Cancer"},{"key":"BFncpgasthep0881_CR67","doi-asserted-by":"publisher","first-page":"G729","DOI":"10.1152\/ajpgi.00511.2005","volume":"290","author":"A Masamune","year":"2006","unstructured":"Masamune A  et al. (2006) Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 290: G729\u2013G736","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFncpgasthep0881_CR68","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1517\/13543784.9.6.1179","volume":"9","author":"SR Bramhall","year":"2000","unstructured":"Bramhall SR (2000) Novel non-operative treatment and treatment strategies in pancreatic cancer. Expert Opin Investig Drugs 9: 1179\u20131195","journal-title":"Expert Opin Investig Drugs"},{"key":"BFncpgasthep0881_CR69","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0006-2952(03)00075-3","volume":"65","author":"R Jaster","year":"2003","unstructured":"Jaster R  et al. (2003) Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 65: 1295\u20131303","journal-title":"Biochem Pharmacol"},{"key":"BFncpgasthep0881_CR70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00006676-200203000-00003","volume":"24","author":"A Masamune","year":"2002","unstructured":"Masamune A  et al. (2002) Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Pancreas 24: 130\u2013138","journal-title":"Pancreas"},{"key":"BFncpgasthep0881_CR71","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0002-9440(10)62293-6","volume":"166","author":"DJ van Westerloo","year":"2005","unstructured":"van Westerloo DJ  et al. (2005) Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 166: 721\u2013728","journal-title":"Am J Pathol"},{"issue":"Suppl 3","key":"BFncpgasthep0881_CR72","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1111\/j.1440-1746.2006.04592.x","volume":"21","author":"MG Bachem","year":"2006","unstructured":"Bachem MG  et al. (2006) Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis. J Gastroenterol Hepatol 21 (Suppl 3): S92\u2013S96","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Nature Clinical Practice Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0881","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:05:28Z","timestamp":1684440328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["BFncpgasthep0881"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0881","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}